VRNA
USDVerona Pharma plc American Depositary Share
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$106.850
Kõrge
$106.910
Madal
$106.910
Maht
1.87M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
9.1B
Tööstusharu
Biotehnoloogia
Riik
United Kingdom
Kauplemisstatistika
Keskmine maht
1.69M
Börs
NGM
Valuuta
USD
52 nädala vahemik
Seotud uudised
Cantor Fitzgerald Suspends Overweight Rating on Verona Pharma PLC ADR, Maintains $100 Price Target
Cantor Fitzgerald suspends Overweight rating on Verona Pharma PLC ADR and Maintains $100 price target
Merck Completes Acquisition of Verona Pharma
Acquisition strengthens Merck's cardio-pulmonary portfolio with addition of Ohtuvayre® (ensifentrine), a first-in-class COPD maintenance treatment, that is expected to grow into the next decade Merck (NYSE:MRK),
Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales
LONDON and RALEIGH, N.C., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (NASDAQ:VRNA) ("Verona Pharma"), a biopharmaceutical company focused on respiratory diseases, which entered into a definitive agreement on
Shareholders of Verona Pharma Approve Proposed Acquisition by Merck
LONDON, U.K., and RALEIGH, N.C., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (NASDAQ:VRNA) ("Verona Pharma"), a biopharmaceutical company focused on respiratory diseases, which entered into a definitive
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.